Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLC590 for Postsurgical Pain Management Following Bunionectomy
NCT07222748Phase 3Active, not recruiting
- Sponsor
- Taiwan Liposome Company
- Start
- Nov 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 3 trial of TLC590 in postoperative pain, sponsored by Taiwan Liposome Company. Started Nov 2025; status: active, not recruiting.
02
Drugs
TLC590
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07222748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07222748.